Detalhe da pesquisa
1.
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A.
Proc Natl Acad Sci U S A
; 117(42): 26340-26346, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020282
2.
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
Am J Hematol
; 95(12): 1457-1465, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777116
3.
A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485.
Haematologica
; 103(6): 982-987, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567781
4.
Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations.
Blood
; 135(24): 2192-2195, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232486
5.
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia.
Haematologica
; 102(8): 1391-1400, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473620
6.
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia.
Br J Haematol
; 175(2): 226-236, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27476855
7.
Crenolanib is active against models of drug-resistant FLT3-ITD-positive acute myeloid leukemia.
Blood
; 122(22): 3607-15, 2013 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24046014
8.
The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/ß-catenin signaling.
Exp Hematol Oncol
; 13(1): 27, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438856
9.
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia.
JCI Insight
; 9(8)2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646934
10.
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).
Leukemia
; 38(1): 45-57, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017103
11.
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia.
Leukemia
; 37(2): 326-338, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376377
12.
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study.
Leukemia
; 37(4): 788-798, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823396
13.
Microenvironmental control of hematopoietic stem cell fate via CXCL8 and protein kinase C.
Cell Rep
; 42(5): 112528, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209097
14.
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors.
Blood Adv
; 6(17): 5049-5060, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797240
15.
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion.
Cancers (Basel)
; 15(1)2022 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612026
16.
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia.
Blood Adv
; 6(5): 1371-1380, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34847232
17.
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
Blood Adv
; 6(19): 5570-5581, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788257
18.
A precision medicine classification for treatment of acute myeloid leukemia in older patients.
J Hematol Oncol
; 14(1): 96, 2021 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162404
19.
Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia.
Cancer Discov
; 11(3): 626-637, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277314
20.
Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq.
Leukemia
; 35(12): 3406-3420, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021247